Community Practice Connections™: Optimizing Management of Uveitic Macular Edema With Potential Treatments on the Horizon

Released On
January 13, 2022

Expires On
January 13, 2023

Media Type

Completion Time
60 minutes

Ophthalmology, Primary Care

Uveitic Macular Edema (UME)

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.


This activity is supported by educational grants from Bausch + Lomb.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This educational program is directed toward ophthalmologists and other health care professionals who are involved in the management of UME.

Program Overview

Macular edema is the leading cause of visual impairment in noninfectious uveitis, but the benefits of corticosteroid treatment for uveitic macular edema (UME) must be balanced with the risks, such as glaucoma and cataracts. New drug delivery systems have been developed in recent years to help decrease these associated risks, and systemic immunomodulators have also been shown to be effective for UME.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from the live Medical Crossfire™: Optimizing Management of Uveitic Macular Edema With Potential Treatments on the Horizon, presented at the American Academy of Ophthalmology Annual Meeting 2021. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with UME, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Characterize treatable targets involved in the pathophysiology of UME
  • Apply imaging findings to the diagnosis and management of patients with UME
  • Identify unmet needs in the treatment of UME with available agents
  • Review safety and efficacy of current and emerging agents for the treatment of UME



Steven Yeh, MD

Stanley Truhlsen Jr Professor of Ophthalmology
Director, Uveitis and Retina Service
Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, NE



Parisa Emami, MD, MPH

Assistant Professor
Director, Uveitis and Ocular Inflammation Service
UC Davis Health
Sacramento, CA


Phoebe Lin, MD, PhD

Associate Professor of Ophthalmology
Casey Eye Institute
Oregon Health & Science University
Portland, OR

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Steven Yeh, MD
  • Consultant: Bausch + Lomb, Clearside Biomedical, Adverum Biotechnologies, Regenxbio Inc.

Parisa Emami, MD, MPH, has no relevant financial relationships with ineligible companies.

Phoebe Lin, MD, PhD, has no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.